MNKD peer analysis
MannKind (MNKD) against its competitors: price, today's move, 1-year return and market value side by side.
MNKD and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AVLN Avalyn Pharma | $25.60 | -0.12% | – | – |
| NRXP NRX Pharmaceuticals | $2.14 | -1.38% | -30.97% | – |
| ORMP Oramed | $4.00 | -2.68% | 67.36% | $170.97M |
| SPRY ARS Pharmaceuticals | $3.05 | -9.76% | -65.96% | – |
| XERS Xeris Biopharma | $10.17 | -5.04% | 4.85% | $1.95B |
| MNKD MannKind | $3.65 | 4.29% | -34.70% | $1.13B |
- MNKD's peers: AVLN (Avalyn Pharma), NRXP (NRX Pharmaceuticals), ORMP (Oramed), SPRY (ARS Pharmaceuticals), XERS (Xeris Biopharma).
Updated 2026-11-03 12:35 UTC